Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 943 shares at $2.62 ($2K) on 2022-11-21, disclosed to the SEC on 2022-11-21.
Open-market purchase of $2k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $2K | — | Filing → |